Search

Author/Creator Holley, Veronica R.

1. Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers. Issue 3 (29th October 2020)

Authors:
Janku, Filip; Sakamuri, Divya; Kato, Shumei; Huang, Helen J.; Call, S. Greg; Naing, Aung; Holley, Veronica R.; Patel, Sapna P.; Amaria, Rodabe N.; Falchook, Gerald S.; Piha‐Paul, Sarina A.; Zinner, Ralph G.; Tsimberidou, Apostolia M.; Hong, David S.; Meric‐Bernstam, Funda
Journal:
Cancer
Issue:
Volume 127:Issue 3(2021)
Page Start:
391
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Issue 3 (1st November 2018)

Authors:
Bhatty, Minny; Kato, Shumei; Piha‐Paul, Sarina A.; Naing, Aung; Subbiah, Vivek; Huang, Helen J.; Karp, Daniel D.; Tsimberidou, Apostolia M.; Zinner, Ralph G.; Hwu, Wen‐Jen; Javle, Milind; Patel, Sapna P.; Hu, Mimi I.; Varadhachary, Gauri R.; Conley, Anthony P.; Ramzanali, Nishma M.; Holley, Veron...
Journal:
Cancer
Issue:
Volume 125:Issue 3(2019)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search